SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (14190)7/20/2000 9:53:36 PM
From: aknahow  Read Replies (1) | Respond to of 17367
 
Yes, I think you are right or some announcement is planned and both partners are interested in providing some sort of surprise.

Do I believe this last part? To some extent not saying anything must have been the result of a decision. BAX could have said we are still waiting for peer reviewed article or have decided not to file a BLA, or we will be filing for approval in Europe, or have decided not to pursue the Meningococcemia indication, or we will be going into clinic for an undisclosed indication before the end of the year. etc. etc. In other words I believe neither Neuprex nor XOMA were mentioned because Baxter/XOMA are going to say something soon. Might be something negative, might be positive. I lean to the positive, if a surprise is intended, since no company plans a negative surprise. But nothing now, was a choice. If I keep repeating this even I might believe it. <g>



To: Cacaito who wrote (14190)7/20/2000 10:38:31 PM
From: Bluegreen  Read Replies (1) | Respond to of 17367
 
What would Baxter have to brag about Neuprex at this point in time to their shareholders.............a reminder that the FDA just slammed the door in their face a few months ago????LOL Even I would be embarrassed to tout future of Neuprex after making in excess of 500 million dollar statements then a short time later the FDA tells me I am stinking up the place. I hear though it was a "compelling" aroma.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News